Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse
about
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorderRat Ultrasonic Vocalizations and Behavioral Neuropharmacology: From the Screening of Drugs to the Study of DiseasePrenatal stress induces increased striatal dopamine transporter binding in adult nonhuman primatesDopamine transporter gene variation modulates activation of striatum in youth with ADHDChanges in Expression of Dopamine, Its Receptor, and Transporter in Nucleus Accumbens of Heroin-Addicted Rats with Brain-Derived Neurotrophic Factor (BDNF) Overexpression.Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firingPharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.Adolescent social defeat alters markers of adult dopaminergic function.Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms.The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila.No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT.HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomesMechanism-based medication development for the treatment of nicotine dependence.HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomesMolecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transportSex differences in response to amphetamine in adult Long-Evans rats performing a delay-discounting taskHIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices.Orquestic regulation of neurotransmitters on reward-seeking behavior.The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters Through a Rho-Dependent Mechanism.Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach.Advances in nicotine research in Addiction Biology.The dopamine transporter role in psychiatric phenotypes.Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription.Psychostimulant-Induced Endoplasmic Reticulum Stress and Neurodegeneration.The Abuse Potential of α-Piperidinopropiophenone (PIPP) and α-Piperidinopentiothiophenone (PIVT), Two New Synthetic Cathinones with Piperidine Ring Substituent.The role of human dopamine transporter in NeuroAIDS.Modulation of dopamine-dependent behaviors by the Caenorhabditis elegans Olig homolog HLH-17.Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration.Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects.Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex.Heterogeneities in Axonal Structure and Transporter Distribution Lower Dopamine Reuptake Efficiency.Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
P2860
Q24629736-E233D44E-8B55-4496-A3EE-DE3718A4654DQ26786512-A491C542-DD6A-4C6F-AD03-FBC64436CA9FQ30429526-1DDE6417-1786-486A-BB6A-6A644A0B70F9Q30495097-C5270DAA-D822-4811-996B-FFA67C82AA79Q33806426-F7FA1155-53A1-48D0-91B4-D95812E6A199Q34070426-B12F5BF5-E90A-4BF5-84AD-0C75F98A4EE2Q34251275-E4AF6363-3890-4AF5-8458-81C069DA7A17Q34709290-F050062C-59AE-49F0-A09B-CB20CF943F98Q34986560-FEF025D5-B3F3-4DB8-968A-8FFB1C7C012AQ35166300-5232AB02-8714-49C8-9A28-00FEF3B8FCF1Q35450098-CD4F475F-16FC-411D-A653-5F8C35075B4DQ36144909-AFA2AE3F-97ED-4504-9902-778529C12509Q36640194-C2D67C0D-7CE3-4BC2-B044-52924CE98716Q36898361-E233407F-5AE5-4175-BA46-1155F7B614FBQ36944251-F4EF2788-BCBE-49F5-8E30-BE8BDE180775Q37018610-79225AE0-159E-4571-ACFD-A1CAD0A42F3FQ37196323-6460AA8C-B481-40BF-B6BE-DC8A9D83A5E7Q37501478-13BC9A65-CD84-4B09-9813-0B18FD9D74FCQ37602020-2C3AB48B-A39B-447E-88AC-C6D109D219D4Q37672037-EE6436B0-9CCF-4A47-AE90-DC922AEC77D0Q38098582-D809CE7F-E64C-4220-8FB0-2241AD40D671Q38233865-9C0ECDB5-661E-42AE-B8F5-B70148680750Q38429066-A41FBBE8-D04C-469B-97FE-295ABC9FC961Q38472884-2CBE5801-D40E-4D79-99A6-DD1166D5EA80Q38495725-410471F4-015B-4F26-B656-55077A38D0E4Q38648135-8934D782-0D63-46F4-9E32-6AC46175B35DQ38811823-CA89C520-F619-4B1B-A0C3-E90CEAC76B65Q38868286-BCCDA628-2992-4F3D-ACA8-CA69479B0236Q38973726-62F3A543-89F9-4485-8392-81FC5FE8C6D6Q41922188-67F28E6E-A28F-4B7B-BF28-563781C1E313Q42490242-133C3003-4928-4E01-9A86-768697000EF2Q42605212-AE23C594-66A5-4C6B-8C3F-AF65390F73D6Q42705031-681069E3-93F1-4322-B526-81C772589635Q45894972-862D5D60-2711-4C63-9C8E-FFA44DC7D6EAQ48248450-833C0398-75EA-4885-AC40-9BFF98D6AF6FQ48428675-DB6E47FE-BBD0-44AB-8E91-1F1A663EBC24Q50072495-6EF6B6A0-3990-4700-9A5C-CC19B7F4359EQ51009516-DBDAE712-B4D7-4C72-9F1F-DBE3AFB95662
P2860
Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Role of the dopamine transport ...... tine, and other drugs of abuse
@ast
Role of the dopamine transport ...... tine, and other drugs of abuse
@en
Role of the dopamine transport ...... tine, and other drugs of abuse
@nl
type
label
Role of the dopamine transport ...... tine, and other drugs of abuse
@ast
Role of the dopamine transport ...... tine, and other drugs of abuse
@en
Role of the dopamine transport ...... tine, and other drugs of abuse
@nl
prefLabel
Role of the dopamine transport ...... tine, and other drugs of abuse
@ast
Role of the dopamine transport ...... tine, and other drugs of abuse
@en
Role of the dopamine transport ...... tine, and other drugs of abuse
@nl
P2860
P1476
Role of the dopamine transport ...... tine, and other drugs of abuse
@en
P2093
P2860
P304
P356
10.2174/187152708786927877
P407
P577
2008-11-01T00:00:00Z